In contrast to CD8+ T cells, Tregs from AML patients are not exhausted but rather hyper-functional as illustrated by a higher migratory and immunosuppressive potential than Tregs from blood and BM of healthy volunteers (37). The gene discussed is CD8A; the disease is acute myeloid leukemia.